Billings Clinic
Especially For:

Clinical Trials

Title   SWOG S1007: Standard Adjuvant Chemotherapy in High-Risk Patients with Oncotype Recurrence Score of 25 or Less
Description   A Phase III Randomized Trial of Standard Adjuvant Endrocrine THerapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor Positive and HER2/neu Negative Breast Cancer with Recurrence core (RS) of 25 or Less
IRB Number   SWOG S1007
Category   Breast Cancer
Inclusion/Notes   Protocol Occurs in 2 Steps:
Step 1-Consent and Oncotype (Genomic Health genetic testing of multiple genetic factors of a patient's tumor). Genomic Health will attempt to negotiate with insurance company for testing. PATIENS WILL NOT BE CHARGED FOR ONCOTYPE TESTING.
Step 2-Randomiazation to treatment.

Specific Inclusion/Exclusion Criteria need to be met to be able to participate in this clinical trial.
Status   Open to Enrollment
Start Date   02/11/2011
Principal Investigator (PI)   Jorge Nieva, MD
Contact Name   Joan Koch, R.N.
Contact Email
Phone   (406) 435-7481
Alternate Phone   (406) 435-7480
Fax   (406) 435-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.